Tech Company Financing Transactions
SerImmune Funding Round
SerImmune, based in Goleta, secured $8 million in funding from Illumina Ventures, MSD Capital and private investors.
Transaction Overview
Company Name
Announced On
6/21/2017
Transaction Type
Venture Equity
Amount
$8,000,000
Round
Undisclosed
Investors
Illumina Ventures (Lead Investor) (Nick Naclerio)
Proceeds Purpose
With the proceeds, SerImmune will expand its immune mapping technology platform and antibody repertoire database while building strategic partnerships.
Company Information
Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
150 Castilian Dr. 100
Goleta, CA 93117
USA
Goleta, CA 93117
USA
Phone
Undisclosed
Website
Email Address
Overview
The immune system is involved in nearly every aspect of human health. Given this, immune repertoires provide an information rich resource to propel therapeutic development and precision medicine. Until now, the relationships between immune repertoires and the universe of possible antigens have remained obscure.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Patrick Daugherty
Chief Technical Officer
John Shon
VP - Bus. Development
Steve Kujawa
VP - Product Management
Jaymie Sawyer
Browse more venture capital transactions:
Prev: 6/21/2017: Intelligent Retinal Imaging Systems venture capital transaction
Next: 6/22/2017: Soldo venture capital transaction
Share this article
Where The Data Comes From
We document every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs